Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586388 | SCV000698743 | benign | not provided | 2017-04-11 | criteria provided, single submitter | clinical testing | Variant summary: The SOS2 c.3489+19C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE Finder predicts the variant may create an SRp40 ESE site at the locus. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large control database ExAC at a frequency of 0.0025052 (281/112168 control chromosomes [4 homozygotes]), which is approximately 1002 times the estimated maximal expected allele frequency of a pathogenic SOS2 variant (0.0000025), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. |
Gene |
RCV000600372 | SCV000714417 | benign | not specified | 2017-04-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002061987 | SCV002415533 | benign | Noonan syndrome 9 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002061987 | SCV002506026 | benign | Noonan syndrome 9 | 2023-10-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002061987 | SCV002762997 | benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Fulgent Genetics, |
RCV002061987 | SCV002805625 | likely benign | Noonan syndrome 9 | 2021-09-30 | criteria provided, single submitter | clinical testing |